CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 32, 2014, Pages

  Amelio, Antonio L ^a,c   Fallahi, Mohammad ^a   Schaub, Franz X ^a   Zhang, Min ^b   Lawani, Mariam B ^a   Alperstein, Adam S ^a   Southern, Mark R ^a   Young, Brandon M ^a   Wu, Lizi ^b   Zajac Kaye, Maria ^b   Kaye, Frederic J ^b   Cleveland, John L ^a   Conkright, Michael D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN REGULATED TRANSCRIPTIONAL COACTIVATOR 1; MASTERMIND LIKE 2 ONCOPROTEIN; MYC PROTEIN; NOTCH RECEPTOR; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CARCINOGENESIS; CELL GROWTH; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA REPLICATION; GAIN OF FUNCTION MUTATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MUCOEPIDERMOID TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA-BINDING PROTEINS; GENE REGULATORY NETWORKS; GENES, MYC; HEK293 CELLS; HUMANS; MICE; MUCOEPIDERMOID TUMOR; NEOPLASMS; NIH 3T3 CELLS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; SALIVARY GLAND NEOPLASMS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 84905984938     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1319176111     Document Type: Article

References (84)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70
2. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144(5):646-674
3. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789-799
4. Mitelman F, Johansson B, Mertens F (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7(4):233-245
5. Rabbitts TH (2009) Commonality but diversity in cancer gene fusions. Cell 137(3): 391-395
6. Tonon G, et al. (2003) t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33(2):208-213
7. Martins C, et al. (2004) A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J Mol Diagn 6(3):205-210
8. Behboudi A, et al. (2005) Clear cell hidradenoma of the skin-A third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion. Genes Chromosomes Cancer 43(2): 202-205
9. Winnes M, et al. (2007) Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. Genes Chromosomes Cancer 46(6):559-563
10. Kazakov DV, et al. (2007) Skin-type hidradenoma of the breast parenchyma with t(11;19) translocation: Hidradenoma of the breast. Am J Dermatopathol 29(5): 457-461
11. Lennerz JKM, Perry A, Mills JC, Huettner PC, Pfeifer JD (2009) Mucoepidermoid carcinoma of the cervix: Another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion. Am J Surg Pathol 33(6):835-843
12. El-Naggar AK, Lovell M, Killary AM, Clayman GL, Batsakis JG (1996) A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormality. Cancer Genet Cytogenet 87(1):29-33
13. Tirado Y, et al. (2007) CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior. Genes Chromosomes Cancer 46(7):708-715
14. Kaye FJ (2006) Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer. Clin Cancer Res 12(13):3878-3881
15. O'Neill ID (2009) t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma. Oral Oncol 45(1):2-9
16. Coxon A, et al. (2005) Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 65(16):7137-7144
17. Wu L, et al. (2005) Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24(13):2391-2402
18. Anzick SL, et al. (2010) Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer 49(1):59-69
19. Amelio AL, et al. (2007) A coactivator trap identifies NONO (p54nrb) as a component of the cAMP-signaling pathway. Proc Natl Acad Sci USA 104(51):20314-20319
20. Hai T, Hartman MG (2001) The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: Activating transcription factor proteins and homeostasis. Gene 273(1):1-11
21. Rehfuss RP, Walton KM, Loriaux MM, Goodman RH (1991) The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A. J Biol Chem 266(28):18431-18434
22. Shen H, et al. (2006) The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev 20(6):675-688
23. Lemaigre FP, Ace CI, Green MR (1993) The cAMP response element binding protein, CREB, is a potent inhibitor of diverse transcriptional activators. Nucleic Acids Res 21(12):2907-2911
24. Conkright MD, et al. (2003) TORCs: Transducers of regulated CREB activity. Mol Cell 12(2):413-423
25. Meyer N, Penn LZ (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8(12):976-990
26. Nilsson JA, Cleveland JL (2003) Myc pathways provoking cell suicide and cancer. Oncogene 22(56):9007-9021
27. Packham G, Cleveland JL (1997) Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways. Oncogene 15(10):1219-1232
28. Zeller KI, et al. (2006) Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci USA 103(47):17834-17839
29. Doherty JR, et al. (2014) Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis. Cancer Res 74(3):908-920
30. Alexandrova N, et al. (1995) The N-terminal domain of c-Myc associates with alphatubulin and microtubules in vivo and in vitro. Mol Cell Biol 15(9):5188-5195
31. Zhang X, et al. (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102(12):4459-4464
32. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV (2003) An integrated database of genes responsive to the Myc oncogenic transcription factor: Identification of direct genomic targets. Genome Biol 4(10):R69
33. Wang H, et al. (2011) Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc Natl Acad Sci USA 108(36):14908-14913
34. Eilers M, Picard D, Yamamoto KR, Bishop JM (1989) Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340(6228):66-68
35. Komiya T, et al. (2006) Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 25(45):6128-6132
36. Chen Z, et al. (2013) Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells. Oncogene, 10.1038/onc.2013.348
37. Nie Z, et al. (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151(1):68-79
38. Lin CY, et al. (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151(1):56-67
39. Fujita PA, et al. (2011) The UCSC Genome Browser database: Update 2011. Nucleic Acids Res 39(Database issue):D876-D882
40. Kent WJ, et al. (2002) The human genome browser at UCSC. Genome Research 12(6): 996-1006, 10.1101/gr.229102
41. Stone J, et al. (1987) Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol 7(5):1697-1709
42. Dang CV, McGuire M, Buckmire M, LeeWM (1989) Involvement of the ?leucine zipper' region in the oligomerization and transforming activity of human c-myc protein. Nature 337(6208):664-666
43. Sawyers CL, Callahan W, Witte ON (1992) Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70(6):901-910
44. Ahn S, et al. (1998) A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol 18(2):967-977
45. Luo Q, et al. (2012) Mechanism of CREB recognition and coactivation by the CREB-regulated transcriptional coactivator CRTC2. Proc Natl Acad Sci USA 109(51):20865-20870
46. Screaton RA, et al. (2004) The CREB coactivator TORC2 functions as a calcium-and cAMP-sensitive coincidence detector. Cell 119(1):61-74
47. Shaw RJ, et al. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310(5754):1642-1646
48. Gu Y, et al. (2012) Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene 31(4):469-479
49. Komiya T, et al. (2010) Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. Oncogene 29(11):1672-1680
50. Ji H, et al. (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448(7155):807-810
51. Partanen JI, Nieminen AI, Mäkelä TP, Klefstrom J (2007) Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc Natl Acad Sci USA 104(37):14694-14699
52. Liang X, Nan K-J, Li Z-L, Xu Q-Z (2009) Overexpression of the LKB1 gene inhibits lung carcinoma cell proliferation partly through degradation of c-myc protein. Oncol Rep 21(4):925-931
53. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30(1):207-210
54. Sanchez-Cespedes M (2011) The role of LKB1 in lung cancer. Fam Cancer 10(3):447-453
55. Network CGAR, et al.; Cancer Genome Atlas Research Network (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489(7417):519-525
56. Rowley JD (1973) Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243(5405):290-293
57. Van Dijk MA, Voorhoeve PM, Murre C (1993) Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 90(13):6061-6065
58. Lee D, Grant A, Buchan D, Orengo C (2003) A structural perspective on genome evolution. Curr Opin Struct Biol 13(3):359-369
59. Vogel C, Bashton M, Kerrison ND, Chothia C, Teichmann SA (2004) Structure, function and evolution of multidomain proteins. Curr Opin Struct Biol 14(2):208-216
60. Linding R, Russell RB, Neduva V, Gibson TJ (2003) GlobPlot: Exploring protein sequences for globularity and disorder. Nucleic Acids Res 31(13):3701-3708
61. McMahon SB, Wood MA, Cole MD (2000) The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 20(2):556-562
62. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL (1999) Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 13(20):2658-2669
63. Jaskoll T, Htet K, Abichaker G, Kaye FJ, Melnick M (2011) CRTC1 expression during normal and abnormal salivary gland development supports a precursor cell origin for mucoepidermoid cancer. Gene Expr Patterns 11(1-2):57-63
64. Knoepfler PS (2008) Why myc? An unexpected ingredient in the stem cell cocktail. Cell Stem Cell 2(1):18-21
65. Wernig M, et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151):318-324
66. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448(7151):313-317
67. Wilson A, et al. (2004) c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18(22):2747-2763
68. Knoepfler PS, Cheng PF, Eisenman RN (2002) N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 16(20):2699-2712
69. Iourgenko V, et al. (2003) Identification of a family of cAMP response elementbinding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci USA 100(21):12147-12152
70. Bittinger MA, et al. (2004) Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Curr Biol 14(23):2156-2161
71. Altarejos JY, Montminy M (2011) CREB and the CRTC co-activators: Sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12(3):141-151
72. Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylationdependent factor CREB. Nat Rev Mol Cell Biol 2(8):599-609
73. Amelio AL, Caputi M, Conkright MD (2009) Bipartite functions of the CREB co-activators selectively direct alternative splicing or transcriptional activation. EMBO J 28(18):2733-2747
74. Wilson BE, Mochon E, Boxer LM (1996) Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 16(10):5546-5556
75. Ke N, et al. (2004) Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 64(22):8208-8212
76. Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M (1998) CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem 273(38): 24884-24890
77. Shankar DB, et al. (2005) The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 7(4):351-362
78. Aggarwal S, Kim S-W, Ryu S-H, Chung W-C, Koo JS (2008) Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein. Cancer Res 68(4):981-988
79. Conkright MD, et al. (2003) Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol Cell 11(4):1101-1108
80. Parker D, et al. (1998) Analysis of an activator:coactivator complex reveals an essential role for secondary structure in transcriptional activation. Mol Cell 2(3):353-359
81. Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26(5):589-595
82. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754-1760
83. McGuffin LJ, Bryson K, Jones DT (2000) The PSIPRED protein structure prediction server. Bioinformatics 16(4):404-405
84. Menssen A, Hermeking H (2002) Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes. Proc Natl Acad Sci USA 99(9):6274-6279.